Chemoinformaics analysis of TRANS-ISOELEMICINE
| Molecular Weight | 208.257 | nRot | 4 |
| Heavy Atom Molecular Weight | 192.129 | nRig | 7 |
| Exact Molecular Weight | 208.11 | nRing | 1 |
| Solubility: LogS | -3.041 | nHRing | 0 |
| Solubility: LogP | 2.738 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 33.1147 |
| nHD | 0 | BPOL | 21.2593 |
| QED | 0.761 |
| Synth | 1.923 |
| Natural Product Likeliness | 0.596 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.953 |
| Pgp-sub | 0.05 |
| HIA | 0.006 |
| CACO-2 | -4.558 |
| MDCK | 0.0000203 |
| BBB | 0.843 |
| PPB | 0.90461 |
| VDSS | 1.412 |
| FU | 0.0840148 |
| CYP1A2-inh | 0.942 |
| CYP1A2-sub | 0.967 |
| CYP2c19-inh | 0.221 |
| CYP2c19-sub | 0.919 |
| CYP2c9-inh | 0.034 |
| CYP2c9-sub | 0.847 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.925 |
| CYP3a4-inh | 0.051 |
| CYP3a4-sub | 0.622 |
| CL | 9.749 |
| T12 | 0.859 |
| hERG | 0.058 |
| Ames | 0.03 |
| ROA | 0.029 |
| SkinSen | 0.952 |
| Carcinogencity | 0.221 |
| EI | 0.877 |
| Respiratory | 0.203 |
| NR-Aromatase | 0.544 |
| Antiviral | No |
| Prediction | 0.652418 |